Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus

Coronavirus disease (COVID-19) appeared in December 2019 in the Chinese city of Wuhan and has quickly become a global pandemic. The disease is caused by the severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2), an RNA beta coronavirus phylogenetically similar to SARS coronavirus. To dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Centonze, Diego, Rocca, Maria A., Gasperini, Claudio, Kappos, Ludwig, Hartung, Hans-Peter, Magyari, Melinda, Oreja-Guevara, Celia, Trojano, Maria, Wiendl, Heinz, Filippi, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038920/
https://www.ncbi.nlm.nih.gov/pubmed/33844056
http://dx.doi.org/10.1007/s00415-021-10545-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038920/
https://www.ncbi.nlm.nih.gov/pubmed/33844056
http://dx.doi.org/10.1007/s00415-021-10545-2

Ejemplares similares